Mar 13, 2017
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Kane Biotech Inc. (KNBIF) trades on the Other OTC in the Biotechnology industry.
Kane Biotech Inc. company overviewThe latest split shown was on March 13, 2017. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
This history records 2 splits between April 28, 2016 and March 13, 2017.
Already premium? Sign in